ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,823 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustrySchlierenCellerys AG
Cellerys AG Logo
Verified· 2 sources

Cellerys AG

Summary

About the company

The core activity of Cellerys AG is the development of therapies for the treatment of autoimmune diseases, particularly multiple sclerosis, through the application of immunotherapies and cell therapies. The company focuses on the development of EpiTCer-based therapies, which aim to modulate the immune response to autoreactive T-cells. Cellerys conducts clinical trials and collaborates with partners such as Novartis and TETEC to develop and market its therapies.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered
3
Immune Tolerance Therapy for Multiple Sclerosis
Immune tolerance therapies for autoimmune diseases, especially multiple sclerosis; development of therapies to restore immune tolerance without immunomodulation or immunosuppression.
CLS12311 therapy
CLS12311 as a treatment for multiple sclerosis; patients' own red blood cells are coupled ex vivo with peptides and, after reinfusion, used to induce antigen-specific tolerance.
RED4MS Clinical Study
Phase Ib/IIa clinical study to evaluate the safety, tolerability and efficacy of CLS12311 in relapsing-remitting multiple sclerosis.
Comparisons

Cellerys AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Cellerys AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Cellerys AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 25
8952 Schlieren

At a glance

Legal form
Corporation
UID
CHE-418.384.245
Founded
2015 · 11 years
Last commercial register change
July 22, 2026
Employees
11 to 20

Knowledge

No knowledge articles yet

Once Cellerys AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

RI
Repertoire Immune Medicines (Switzerland) AG
Schlieren
SB
Swiss Bioscience GmbH
Schlieren
LB
LimmaTech Biologics AG
Schlieren
CA
CUTISS AG
Schlieren
MT
Memo Therapeutics AG
Schlieren
EA
Evax AG
Zurich
SA
Stallergenes AG
Dietlikon
DT
Denali Therapeutics CH GmbH
Zurich